Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (66)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Foka, Z.J.
Right arrow Articles by Kotsis, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foka, Z.J.
Right arrow Articles by Kotsis, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 15, No. 2, 458-462, February 2000
© 2000 European Society of Human Reproduction and Embryology

Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages

Z.J. Foka1,4, A.F. Lambropoulos1, H. Saravelos2, G.B. Karas1, A. Karavida2, T. Agorastos2, V. Zournatzi2, P.E. Makris3, J. Bontis2 and A. Kotsis1

1 Biology Department, 2 2nd University Department of Obstetrics and Gynecology, Hippokration Hospital and 3 Thrombosis and Haemostasis Unit, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, 54008 Thessaloniki, Greece

The aim of this study was to investigate the relationship between recurrent miscarriages and factor V Leiden, prothrombin G20210A and C677T methylenetetrahydrofolate reductase (MTHFR) mutations. In this case-control study the prevalence of factor V Leiden, prothrombin G20210A and C677T methylenetetrahydrofolate reductase mutations was determined in a consecutive series of 80 recurrent miscarriage patients and 100 controls. Fifteen of 80 recurrent miscarriage patients and four out of 100 controls carried the factor V Leiden mutation (19 versus 4%, P = 0.003, odds ratio 5.5, 95% confidence interval (CI): 1.7–17). Seven of 80 recurrent miscarriage patients and two of 100 controls were carriers of the prothrombin G20210A mutation (9 versus 2%, P = 0.038, odds ratio 4.6, 95% CI: 0.9–23.2). Six of 80 recurrent miscarriage women and 15 of 100 controls were homozygotes for the C677T MTHFR mutation (8 versus 15%, P = 0.134, odds ratio: 0.4, 95% CI: 0.1–1.2). Our results suggest that the presence of factor V Leiden and prothrombin G20210A polymorphism, but not MTHFR C677T homozygosity, could be additional risk factors for recurrent miscarriages. Furthermore, it was suggested that the prevalence of factor V Leiden and prothrombin G20210A mutations is more prominent in second trimester, primary fetal losses and it is independent of the existence of additional pathology predisposing to recurrent fetal losses.

Key words: factor V Leiden/miscarriage/MTHFR C677T mutation/prothrombin G20210A mutation

4 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
T. Tamura and M. F. Picciano
Folate and human reproduction
Am. J. Clinical Nutrition, May 1, 2006; 83(5): 993 - 1016.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
V. Wiwanitkit
Roles of Methylenetetrahydrofolate Reductase C677T Polymorphism in Repeated Pregnancy Loss
Clinical and Applied Thrombosis/Hemostasis, July 1, 2005; 11(3): 343 - 345.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
C. J. Glueck, P. Wang, N. Goldenberg, and L. Sieve
Pregnancy Loss, Polycystic Ovary Syndrome, Thrombophilia, Hypofibrinolysis, Enoxaparin, Metformin
Clinical and Applied Thrombosis/Hemostasis, October 1, 2004; 10(4): 323 - 334.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
G. Kovalevsky, C. R. Gracia, J. A. Berlin, M. D. Sammel, and K. T. Barnhart
Evaluation of the Association Between Hereditary Thrombophilias and Recurrent Pregnancy Loss: A Meta-analysis
Arch Intern Med, March 8, 2004; 164(5): 558 - 563.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Tsanadis, G. Vartholomatos, I. Korkontzelos, F. Avgoustatos, G. Kakosimos, A. Sotiriadis, A. Tatsioni, A. Eleftheriou, and D. Lolis
Polycystic ovarian syndrome and thrombophilia
Hum. Reprod., February 1, 2002; 17(2): 314 - 319.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
J. K. Lynch, K. B. Nelson, C. J. Curry, and J. K. Grether
Cerebrovascular Disorders in Children With the Factor V Leiden Mutation
J Child Neurol, October 1, 2001; 16(10): 735 - 744.
[Abstract] [PDF]


Home page
Reproductive SciencesHome page
C. Kurz, C. B. Tempfer, S. Boecskoer, G. Unfried, F. Nagele, and L. A. Hefler
The PROGINS Progesterone Receptor Gene Polymorphism and Idiopathic Recurrent Miscarriage
Reproductive Sciences, September 1, 2001; 8(5): 295 - 298.
[Abstract] [PDF]


Home page
Hum ReprodHome page
C. Tempfer, G. Unfried, R. Zeillinger, L. Hefler, F. Nagele, and J. C. Huber
Endothelial nitric oxide synthase gene polymorphism in women with idiopathic recurrent miscarriage
Hum. Reprod., August 1, 2001; 16(8): 1644 - 1647.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
W. Pickering, K. Marriott, and L. Regan
G20210A Prothrombin Gene Mutation: Prevalence in a Recurrent Miscarriage Population
Clinical and Applied Thrombosis/Hemostasis, January 1, 2001; 7(1): 25 - 28.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.